Systemic T-cell and humoral responses against cancer testis antigens in hepatocellular carcinoma patients
Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related deaths worldwide due to high recurrence rates after curative treatment and being frequently diagnosed at an advanced stage. Immune-checkpoint inhibition (ICPI) has yielded impressive clinical successes in a variety of solid...
Main Authors: | Lisanne Noordam, Monique T.A. de Beijer, Shanta Mancham, Isabel Vogler, Patrick P.C. Boor, Valeska de Ruiter, Robbie Luijten, Jan N.M. IJzermans, Ugur Sahin, Marco J. Bruno, Dave Sprengers, Sonja I. Buschow, Jaap Kwekkeboom |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-12-01
|
Series: | OncoImmunology |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/2162402X.2022.2131096 |
Similar Items
-
Expression of Cancer Testis Antigens in Tumor-Adjacent Normal Liver Is Associated with Post-Resection Recurrence of Hepatocellular Carcinoma
by: Lisanne Noordam, et al.
Published: (2021-05-01) -
Engaging stimulatory immune checkpoint interactions in the tumour immune microenvironment of primary liver cancers – how to push the gas after having released the brake
by: Yannick S. Rakké, et al.
Published: (2024-02-01) -
Immunopeptidome of hepatocytes isolated from patients with HBV infection and hepatocellular carcinoma
by: Monique T.A. de Beijer, et al.
Published: (2022-11-01) -
PD-L1, Galectin-9 and CD8+ tumor-infiltrating lymphocytes are associated with survival in hepatocellular carcinoma
by: Kostandinos Sideras, et al.
Published: (2017-02-01) -
Empirical Evaluation of the Use of Computational HLA Binding as an Early Filter to the Mass Spectrometry-Based Epitope Discovery Workflow
by: Rachid Bouzid, et al.
Published: (2021-05-01)